Table 3.

Complications of gastric cancer patients who underwent RADG or LADG.

Complications	RADG (n = 285)	LADG (n = 285)	P value
Patients with complications, n (%)	30 (10.5%)	36 (12.6%)	0.432a
single complication	25 (8.8%)	26 (9.1%)	0.883a
multiple complications	5 (1.8%)	10 (3.5%)	0.191a
Overall complications, n (%)	35 (12.3%)	48 (16.8%)	0.123a
Surgical complications, n (%)	19 (6.7%)	36 (12.6%)	0.016a
wound infection/liquefaction	5 (1.8%)	6 (2.1%)	0.761a
delayed gastric emptying	3 (1.1%)	4 (1.4%)	1.000b
intestinal obstruction	0 (0.0%)	3 (1.1%)	0.247b
intra-abdominal hemorrhage	2 (0.7%)	2 (0.7%)	1.000b
intra-abdominal effusion/abscess	2 (0.7%)	2 (0.7%)	1.000b
duodenal stump leakage	5 (1.8%)	6 (2.1%)	0.761a
gastrojejunostomy anastomotic leakage	0 (0.0%)	3 (1.1%)	0.247b
gastrojejunostomy anastomotic bleeding	1 (0.4%)	1 (0.4%)	1.000b
gastroduodenal anastomotic bleeding	0 (0.0%)	1 (0.4%)	1.000c
pancreatic fistula	1 (0.4%)	8 (2.8%)	0.044b
General complications, n (%)	16 (5.6%)	12 (4.2%)	0.438a
deep vein thrombosis	2 (0.7%)	0 (0.0%)	0.479b
pulmonary embolism	1 (0.4%)	0 (0.0%)	1.000c
pneumonia	5 (1.8%)	6 (2.1%)	0.761a
pleural effusion	1 (0.4%)	3 (1.1%)	0.616b
heart failure	1 (0.4%)	1 (0.4%)	1.000b
myocardial infarction	1 (0.4%)	0 (0.0%)	1.000c
atrial fibrillation	1 (0.4%)	0 (0.0%)	1.000c
sepsis	1 (0.4%)	1 (0.4%)	1.000b
cerebral hemorrhage	1 (0.4%)	0 (0.0%)	1.000c
cerebral infarction	1 (0.4%)	0 (0.0%)	1.000c
urinary tract infection	1 (0.4%)	1 (0.4%)	1.000b
Clavien-Dindo classification, n (%)
I	3 (1.1%)	7 (2.5%)	0.202a
II	16 (5.6%)	21 (7.4%)	0.395a
IIIa	8 (2.8%)	13 (4.6%)	0.266a
IIIb	4 (1.4%)	6 (2.1%)	0.523a
IV	1 (0.4%)	0 (0.0%)	1.000c
V	3 (1.1%)	2 (0.7%)	1.000b
≥III	15 (5.3%)	21 (7.4%)	0.302a
Reoperation, n (%)	5 (1.8%)	6 (2.1%)	0.761a
Mortality, n (%)	3 (1.1%)	2 (0.7%)	1.000b

LADG: laparoscopic assisted distal gastrectomy; RADG: robotic assisted distal gastrectomy.

^aPearson’s chi-squared test.

^bContinuous correction chi-squared test.

^cFisher’s exact test.